Inmune Bio, Inc. Quarterly Current Ratio in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inmune Bio, Inc. quarterly Current Ratio history and growth rate from Q1 2020 to Q3 2024.
  • Inmune Bio, Inc. Current Ratio for the quarter ending September 30, 2024 was 218 %, a 51.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 218 -234 -51.8% Sep 30, 2024
Q2 2024 231 -354 -60.5% Jun 30, 2024
Q1 2024 265 -586 -68.9% Mar 31, 2024
Q4 2023 347 -849 -71% Dec 31, 2023
Q3 2023 452 -1.32K -74.5% Sep 30, 2023
Q2 2023 585 -1.6K -73.2% Jun 30, 2023
Q1 2023 852 -1.06K -55.5% Mar 31, 2023
Q4 2022 1.2K -663 -35.7% Dec 31, 2022
Q3 2022 1.77K +2.19 +0.12% Sep 30, 2022
Q2 2022 2.19K +488 +28.7% Jun 30, 2022
Q1 2022 1.92K +329 +20.7% Mar 31, 2022
Q4 2021 1.86K +722 +63.6% Dec 31, 2021
Q3 2021 1.77K +721 +68.8% Sep 30, 2021
Q2 2021 1.7K +861 +103% Jun 30, 2021
Q1 2021 1.59K +384 +32% Mar 31, 2021
Q4 2020 1.14K Dec 31, 2020
Q3 2020 1.05K Sep 30, 2020
Q2 2020 839 Jun 30, 2020
Q1 2020 1.2K Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.